Diagnostic Value of PET/MR with DWI for Burkitt Lymphoma.
Chiara GiraudoRossella SimeoneMargherita FosioDario MarinoDiego CecchinPublished in: Diagnostics (Basel, Switzerland) (2021)
18F-FDG-PET/MR images, including DWI, of a 46-year-old male admitted to the Emergency Room of our tertiary center, who was suffering from diplopia, left orbital pain, and a headache for two weeks, demonstrated multiple hepatic nodules, a pancreatic mass, and skeletal metastases, in addition to thrombosis of the left cavernous sinus, thickening of the small intestine, and a large hepatic lesion identified at head and neck MR and whole-body CT, respectively. Hepatic and bone marrow biopsies revealed the diagnosis of Burkitt lymphoma. After four cycles of rituximab, cyclophosphamide, doxorubicin, vincristine, methotrexate/ifosfamide, etoposide, and high dose cytarabine (R- CODOX-M/IVAC), a complete metabolic response occurred.
Keyphrases
- high dose
- contrast enhanced
- diffusion weighted
- positron emission tomography
- diffuse large b cell lymphoma
- computed tomography
- pet ct
- diffusion weighted imaging
- bone marrow
- stem cell transplantation
- low dose
- pet imaging
- magnetic resonance imaging
- magnetic resonance
- chronic pain
- emergency department
- drug delivery
- pulmonary embolism
- public health
- acute myeloid leukemia
- mesenchymal stem cells
- neuropathic pain
- healthcare
- dual energy
- pain management
- spinal cord injury
- machine learning
- spinal cord
- image quality
- cancer therapy
- hodgkin lymphoma
- ultrasound guided